Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Corbus Pharmaceuticals Holdings Inc CRBP

Healthcare Biotechnology
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation... see more

Current News (NDAQ:CRBP)

Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

GlobeNewswire 3 days ago

Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2026

Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss

GlobeNewswire December 11, 2025

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025

GlobeNewswire December 10, 2025

Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire November 12, 2025

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire November 6, 2025

Corbus Pharmaceuticals Announces Pricing of Public Offering

GlobeNewswire October 31, 2025

Corbus Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire October 30, 2025

Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25

GlobeNewswire October 18, 2025
View More News ››

Opinion & Analysis (NDAQ:CRBP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CRBP)

Buy buddy buy because it's taking off this morning.

Otherwise FOMO for you fellas out there today anyway,and what about Wal-Mart
coolfooldumbguy - December 11, 2025

BUY BUY BUY BUY BUY

Bought friday at 16.97 sold 39.50
Nibinator - January 27, 2024

Incredible Value. ENTG at about 25% of One Years Revenue

.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for...
Wrywisdom - August 10, 2022

Planet 13 and AMA/1933 Las Vegas

Good Products:  https://www.instagram.com/p/COvammkL6Yf/
INVESTigator1 - May 11, 2021

TGIFF 1933 Industries - Nevada dispensaries everywhere...

Deliveries of flower, concentrates, badder, diamonds, exotics, crumble, pre-rolls, disposable vapes, CBDs & more... Can't keep...
INVESTigator1 - May 7, 2021

1933 Industries Preferred Supplier Las Vegas & Nevada

If anyone is looking for a cannabis stock that will easily quadruple and more this year – TGIFF (US) TGIF (CN) is the ticker with the AMA...
INVESTigator1 - May 5, 2021
View more Bullboard ››

New Pacific Metals Corp

New Pacific Metals Corp

New Pacific Metals Corp., together with its subsidiaries, engages in the exploration and development of mineral properties in ...
View More »

Podcasts